Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Jinan Tantu Chemicals

02 3Porton Pharma Solutions

03 3Hebi Xinhe Pharmaceutical

04 7Suzhou Biosyntech

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

CAS Number : 1375470-88-4

End Use API : Ubrogepant

About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...

Jinan Tantu Chemicals

02

2024 ACI Convention
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

CAS Number : 1456803-37-4

End Use API : Ubrogepant

About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...

Porton Company Banner

03

2024 ACI Convention
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

CAS Number : 1375541-21-1

End Use API : Ubrogepant

About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...

Jinan Tantu Chemicals

04

2024 ACI Convention
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

CAS Number : 1375470-88-4

End Use API : Ubrogepant

About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...

Porton Company Banner

05

2024 ACI Convention
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

CAS Number : 1455358-16-3

End Use API : Ubrogepant

About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...

Porton Company Banner

06

2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
arrow

CAS Number : CAS-1455358-14-1

End Use API : Ubrogepant

About The Company : Hebi Xinhe Pharmaceutical Co., Ltd. is a subsidiary of Tianjin Zhennuo Pharmaceutical Group Co., Ltd., with a registered capital of CNY 100 million. Located in ...

blank

07

2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
arrow

CAS Number : CAS-1455358-16-3

End Use API : Ubrogepant

About The Company : Hebi Xinhe Pharmaceutical Co., Ltd. is a subsidiary of Tianjin Zhennuo Pharmaceutical Group Co., Ltd., with a registered capital of CNY 100 million. Located in ...

blank

08

2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
arrow

CAS Number : CAS-1456803-37-4

End Use API : Ubrogepant

About The Company : Hebi Xinhe Pharmaceutical Co., Ltd. is a subsidiary of Tianjin Zhennuo Pharmaceutical Group Co., Ltd., with a registered capital of CNY 100 million. Located in ...

blank

09

2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
arrow

CAS Number : 1455358-14-1

End Use API : Ubrogepant

About The Company : Suzhou Biosyntech is an R&D driven supplier for the Pharma market, the major business is on API and intermediates. Biosyntech has the ability to provide service...

blank

10

2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
arrow

CAS Number : 1375470-88-4

End Use API : Ubrogepant

About The Company : Suzhou Biosyntech is an R&D driven supplier for the Pharma market, the major business is on API and intermediates. Biosyntech has the ability to provide service...

blank